Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1995 Apr;58(4):417–421. doi: 10.1136/jnnp.58.4.417

Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway.

R Midgard 1, G Albrektsen 1, T Riise 1, G Kvåle 1, H Nyland 1
PMCID: PMC1073425  PMID: 7738546

Abstract

A longitudinal, population based study of life expectancy in multiple sclerosis was performed in the county of Møre and Romsdal, Norway during the period 1950-84. A total of 251 patients with multiple sclerosis (110 men, 141 women, mean age at onset of disease 33.6 years) were included. The mean follow up time was 18.1 years. At the end of the study period 70 patients had died. Fifty four (77.1%) of these had multiple sclerosis as the underlying or contributing cause of death on the death certificates. Young age at onset, initial remitting clinical course, and the presence of sensory symptoms at onset were significantly associated with longer survival.

Full text

PDF
417

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clark V. A., Detels R., Visscher B. R., Valdiviezo N. L., Malmgren R. M., Dudley J. P. Factors associated with a malignant or benign course of multiple sclerosis. JAMA. 1982 Aug 20;248(7):856–860. [PubMed] [Google Scholar]
  2. Confavreux C., Aimard G., Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain. 1980 Jun;103(2):281–300. doi: 10.1093/brain/103.2.281. [DOI] [PubMed] [Google Scholar]
  3. HYLLESTED K. Lethality, duration, and mortality of disseminated sclerosis in Denmark. Acta Psychiatr Scand. 1961;36:553–564. doi: 10.1111/j.1600-0447.1961.tb01774.x. [DOI] [PubMed] [Google Scholar]
  4. IPSEN J., Jr Life expectancy and probable disability multiple sclerosis. N Engl J Med. 1950 Dec 7;243(23):909–913. doi: 10.1056/NEJM195012072432303. [DOI] [PubMed] [Google Scholar]
  5. Kurtzke J. F., Beebe G. W., Nagler B., Kurland L. T., Auth T. L. Studies on the natural history of multiple sclerosis--8. Early prognostic features of the later course of the illness. J Chronic Dis. 1977 Dec;30(12):819–830. doi: 10.1016/0021-9681(77)90010-8. [DOI] [PubMed] [Google Scholar]
  6. Leibowitz U., Alter M. Clinical factors associated with increased disability in multiple sclerosis. Acta Neurol Scand. 1970;46(1):53–70. doi: 10.1111/j.1600-0404.1970.tb05604.x. [DOI] [PubMed] [Google Scholar]
  7. Leibowitz U., Kahana E., Alter M. Survival and death in multiple sclerosis. Brain. 1969 Mar;92(1):115–130. doi: 10.1093/brain/92.1.115. [DOI] [PubMed] [Google Scholar]
  8. MCALPINE D. The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. Brain. 1961 Jun;84:186–203. doi: 10.1093/brain/84.2.186. [DOI] [PubMed] [Google Scholar]
  9. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  10. Midgard R., Riise T., Nyland H. Epidemiologic trends in multiple sclerosis in Møre and Romsdal, Norway: a prevalence/incidence study in a stable population. Neurology. 1991 Jun;41(6):887–892. doi: 10.1212/wnl.41.6.887. [DOI] [PubMed] [Google Scholar]
  11. Poser S., Kurtzke J. F., Poser W., Schlaf G. Survival in multiple sclerosis. J Clin Epidemiol. 1989;42(2):159–168. doi: 10.1016/0895-4356(89)90089-9. [DOI] [PubMed] [Google Scholar]
  12. Poser S., Raun N. E., Poser W. Age at onset, initial symptomatology and the course of multiple sclerosis. Acta Neurol Scand. 1982 Sep;66(3):355–362. doi: 10.1111/j.1600-0404.1982.tb06856.x. [DOI] [PubMed] [Google Scholar]
  13. Riise T., Grønning M., Aarli J. A., Nyland H., Larsen J. P., Edland A. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models. J Clin Epidemiol. 1988;41(10):1031–1036. doi: 10.1016/0895-4356(88)90041-8. [DOI] [PubMed] [Google Scholar]
  14. Riise T., Grønning M., Fernández O., Lauer K., Midgard R., Minderhoud J. M., Nyland H., Pálffy G., Poser S., Aarli J. A. Early prognostic factors for disability in multiple sclerosis, a European multicenter study. Acta Neurol Scand. 1992 Mar;85(3):212–218. doi: 10.1111/j.1600-0404.1992.tb04031.x. [DOI] [PubMed] [Google Scholar]
  15. Runmarker B., Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain. 1993 Feb;116(Pt 1):117–134. doi: 10.1093/brain/116.1.117. [DOI] [PubMed] [Google Scholar]
  16. Visscher B. R., Liu K. S., Clark V. A., Detels R., Malmgren R. M., Dudley J. P. Onset symptoms as predictors of mortality and disability in multiple sclerosis. Acta Neurol Scand. 1984 Nov;70(5):321–328. doi: 10.1111/j.1600-0404.1984.tb00832.x. [DOI] [PubMed] [Google Scholar]
  17. Weinshenker B. G., Ebers G. C. The natural history of multiple sclerosis. Can J Neurol Sci. 1987 Aug;14(3):255–261. doi: 10.1017/s0317167100026573. [DOI] [PubMed] [Google Scholar]
  18. Weinshenker B. G., Rice G. P., Noseworthy J. H., Carriere W., Baskerville J., Ebers G. C. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain. 1991 Apr;114(Pt 2):1045–1056. doi: 10.1093/brain/114.2.1045. [DOI] [PubMed] [Google Scholar]
  19. Wynn D. R., Rodriguez M., O'Fallon W. M., Kurland L. T. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology. 1990 May;40(5):780–786. doi: 10.1212/wnl.40.5.780. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES